OGEN vs PPL · rev $37.7K vs P/E 22, rev $8.46B
Oragenics Inc (OGEN) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
Latest reported PPL revenue for 2024-12-31 was $8.46B. Net income was $888.0M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
OGEN currently screens at market cap $2.7M. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the OGEN and PPL stock pages for the full models.
Not investment advice.